704 related articles for article (PubMed ID: 26294067)
1. IgD multiple myeloma: Clinical, biological features and prognostic value of the serum free light chain assay.
Djidjik R; Lounici Y; Chergeulaïne K; Berkouk Y; Mouhoub S; Chaib S; Belhani M; Ghaffor M
Pathol Biol (Paris); 2015 Sep; 63(4-5):210-4. PubMed ID: 26294067
[TBL] [Abstract][Full Text] [Related]
2. IgD-λ multiple myeloma with excessive excretion of free light chains: a diagnostic trap in the identification of monoclonal gammopathies.
Zahir H; Tali A; Rachidi M; Mouhib H; Daif H; Ait Ouzdi Z; Haouach K; Chabaa L
Ann Biol Clin (Paris); 2019 Feb; 77(1):107-111. PubMed ID: 30799291
[TBL] [Abstract][Full Text] [Related]
3. IgD multiple myeloma. Review of 133 cases.
Jancelewicz Z; Takatsuki K; Sugai S; Pruzanski W
Arch Intern Med; 1975 Jan; 135(1):87-93. PubMed ID: 1111472
[TBL] [Abstract][Full Text] [Related]
4. IgD paraproteinemias.
Tichý M; Matĕja F; Urban P; Matuska M
Neoplasma; 1993; 40(1):59-61. PubMed ID: 8350950
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of amyloidosis in myeloma. Clinical, biological and prognostic study].
Zamora P; Fernández Martín J; Barbado FJ; Vicandi B; Encinas A; Gil A; Arnalich F; Vázquez JJ
Rev Clin Esp; 1986 May; 178(9):428-31. PubMed ID: 3090651
[No Abstract] [Full Text] [Related]
6. Strengths and weaknesses of methods for identifying monoclonal free light chains of Ig: examples from two cases with renal disease.
Levinson SS
Clin Chem Lab Med; 2016 Jun; 54(6):1039-43. PubMed ID: 26368046
[TBL] [Abstract][Full Text] [Related]
7. Kidney failure as an unusual initial presentation of biclonal gammopathy (IgD multiple myeloma associated with light chain disease)--a case report.
Rabrenović V; Mijušković Z; Marjanović S; Rabrenović M; Jovanović D; Antić S; Ignjatović L; Petrović M; Pilcević D
Vojnosanit Pregl; 2015 Feb; 72(2):196-9. PubMed ID: 25831916
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma.
Kyrtsonis MC; Vassilakopoulos TP; Kafasi N; Sachanas S; Tzenou T; Papadogiannis A; Galanis Z; Kalpadakis C; Dimou M; Kyriakou E; Angelopoulou MK; Dimopoulou MN; Siakantaris MP; Dimitriadou EM; Kokoris SI; Panayiotidis P; Pangalis GA
Br J Haematol; 2007 May; 137(3):240-3. PubMed ID: 17408464
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin D multiple myeloma.
Lin TL; Shih LY; Dunn P; Wang PN; Wu JH; Kao MC
Chang Gung Med J; 2000 Aug; 23(8):451-7. PubMed ID: 11039246
[TBL] [Abstract][Full Text] [Related]
10. [Systemic amyloidosis associated with IgD-λ multiple myeloma].
Nagamachi Y; Yamauchi N; Muramatsu H; Inomata H; Nozawa E; Koyama R; Ihara K; Nishisato T; Yamada H; Yano T; Kikuchi S; Hirako T; Kitaoka K; Ono K; Ihara H; Kato J
Rinsho Ketsueki; 2011 Dec; 52(12):1888-92. PubMed ID: 22241157
[TBL] [Abstract][Full Text] [Related]
11. [IgD-multiple myeloma. Review of 102 cases reported in the literature (author's transl)].
Knolle J; Meyer KH
Immun Infekt; 1975 Jul; 3(3):125-34. PubMed ID: 810409
[TBL] [Abstract][Full Text] [Related]
12. [Multiple myeloma with D immunoglobulin].
Benchekroun L; Ouzzif Z; Bouabdillah M; Jaouhar N; Aoufir F; Aoufi F; Chabraoui L
Ann Biol Clin (Paris); 2011; 69(5):581-7. PubMed ID: 22008139
[TBL] [Abstract][Full Text] [Related]
13. Correlation of serum immunoglobulin free light chain quantification with urinary Bence Jones protein in light chain myeloma.
Abraham RS; Clark RJ; Bryant SC; Lymp JF; Larson T; Kyle RA; Katzmann JA
Clin Chem; 2002; 48(4):655-7. PubMed ID: 11901068
[No Abstract] [Full Text] [Related]
14. Prognostic Value of Serum Free Light Chains Measurements in Multiple Myeloma Patients.
García de Veas Silva JL; Bermudo Guitarte C; Menéndez Valladares P; Rojas Noboa JC; Kestler K; Duro Millán R
PLoS One; 2016; 11(11):e0166841. PubMed ID: 27893836
[TBL] [Abstract][Full Text] [Related]
15. Immunodiagnosis of IgD multiple myeloma. A report of 17 cases.
Chernokhvostova EV; Batalova TN; German GP; Andreyeva NE
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(4):539-52. PubMed ID: 6170548
[TBL] [Abstract][Full Text] [Related]
16. IgD myeloma with myelofibrosis and amyloidosis.
Udoji WC; Pemmaraju S
Arch Pathol Lab Med; 1977 Jan; 101(1):10-3. PubMed ID: 401635
[TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin D multiple myeloma: presenting features, response to therapy, and survival in a series of 53 cases.
Bladé J; Lust JA; Kyle RA
J Clin Oncol; 1994 Nov; 12(11):2398-404. PubMed ID: 7964956
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin D myeloma: clinical features and outcome in the era of novel agents.
Zagouri F; Kastritis E; Symeonidis AS; Giannakoulas N; Katodritou E; Delimpasi S; Repousis P; Terpos E; Dimopoulos MA;
Eur J Haematol; 2014 Apr; 92(4):308-12. PubMed ID: 24460646
[TBL] [Abstract][Full Text] [Related]
19. Kappa and lambda light chain disease: survival rates and clinical manifestations.
Shustik C; Bergsagel DE; Pruzanski W
Blood; 1976 Jul; 48(1):41-51. PubMed ID: 820387
[TBL] [Abstract][Full Text] [Related]
20. [Primary amyloidosis associated with IgD-lambda M-proteinemia].
Kimura S; Iwatsuka R; Aoki T; Odawara J; Asada N; Yamakura M; Takeuchi M; Matsue K
Rinsho Ketsueki; 2007 Dec; 48(12):1555-8. PubMed ID: 18203516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
